CLASS II Drug recall · Reported 14 Oct 2020 · FDA Enforcement Report

Diethylpropion, 75 mg tablets, Rx only recalled

Calvin Scott is recalling Diethylpropion, 75 mg tablets, Rx only, distributed in California, Idaho, Illinois, Oklahoma, Rhode Island. The recall was initiated on 16 Sep 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: CS19192, CS19226, CS19263, Exp 10/20; CS19300, Exp 7/21; CS19338, Exp 8/21; CS20034, Exp 10/21; CS20077, Exp 1/22, CS20165, CS20241, Exp 4/22
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0010-2021
FDA event ID
86442
Recalling firm
Calvin Scott, Albuquerque, NM
Classification
Class II
Status
Terminated
Recall initiated
16 Sep 2020
FDA classified
2 Oct 2020
Reported
14 Oct 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

16 Sep 2020Recall initiated by company
2 Oct 2020Classified by FDA+16 days
14 Oct 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Diethylpropion, 75 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1477-01

Where it was distributed

Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI

CaliforniaIdahoIllinoisOklahomaRhode Island

Questions about this recall

Why was it recalled?

cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Which lots are affected?

Lot #: CS19192, CS19226, CS19263, Exp 10/20; CS19300, Exp 7/21; CS19338, Exp 8/21; CS20034, Exp 10/21; CS20077, Exp 1/22, CS20165, CS20241, Exp 4/22

Where was it sold?

Repacked drug products distributed to 12 physician consignees located in the following states: CA, ID, IL,OK, RI

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 86442

This product is part of a recall event; the main page for the event is Diethylpropion, 25 mg tablets, Rx only recalled.

More recalls from Calvin Scott

All 24

Other Diethylpropion recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDiethylpropion, 25 mg tablets, Rx only recalledCalvin ScottPotency & Assay5 states